Found 0 matching trials
Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
PHASE3Study of masitinib plus docetaxel as first-line chemotherapy in men with me...
Location
Centre Hospitalier Universitaire de Sherbrooke
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis
PHASE3The purpose of this study is to compare the safety and efficacy of masitini...
Location
"St. Ivan Rilski" University Multiprofile Hospital for Active Treatment
Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids
PHASE3The study objective is to compare the efficacy and the safety of masitinib ...
Location
Dr. Georgi Stranski University Hospital
Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation
PHASE2The objective is to compare efficacy and safety of AB1010 at 3 or 6 mg/kg/d...
Location
Multiple Locations
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
PHASE3To evaluate the efficacy and safety of oral masitinib versus placebo in the...
Location
Service de Neurologie Hôpital Henri-Mondor
Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer
PHASE3The objective is to compare the efficacy and safety of masitinib in combina...
Location
Hopital Europeen George Pomipidou, Hepato-Gastro-enterologie, 20 rue Leblanc
Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib
PHASE2The objective is to compare efficacy and safety of masitinib at 12 mg/kg/da...
Location
Institute Gustave Roussy (IGR)
Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer
PHASE2A prospective, multicentre, open-label, randomized, phase 2-3 study to comp...
Location
University Hospital Olomouc
Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3
PHASE2This phase 2 study was designed to assess the safety and efficacy of masiti...
Location
Hopital Saint Louis
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis
PHASE3The objective of this study is to compare the safety and efficacy of masiti...
Location
UC Davis Health System , Department of Dermatology